Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 4
1997 5
1998 2
1999 1
2000 1
2007 3
2008 4
2009 5
2010 1
2011 3
2012 3
2013 4
2014 4
2015 3
2016 3
2017 3
2018 2
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.
Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M. Hidaka H, et al. Among authors: igura t. Clin Gastroenterol Hepatol. 2019 May;17(6):1192-1200. doi: 10.1016/j.cgh.2018.11.047. Epub 2018 Nov 28. Clin Gastroenterol Hepatol. 2019. PMID: 30502505 Free article. Clinical Trial.
Usefulness of the multimodality fusion imaging for the diagnosis and treatment of hepatocellular carcinoma.
Makino Y, Imai Y, Igura T, Ohama H, Kogita S, Sawai Y, Fukuda K, Ohashi H, Murakami T. Makino Y, et al. Among authors: igura t. Dig Dis. 2012;30(6):580-7. doi: 10.1159/000343070. Epub 2012 Dec 13. Dig Dis. 2012. PMID: 23258098 Review.
Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial.
Hidaka H, Kokubu S, Sato T, Katsushima S, Izumi N, Igura T, Asahara S, Notsumata K, Osaki Y, Tsuji K, Kawanaka H, Akahoshi T, Hirota S, Matsutani S; NPB-06 study group. Hidaka H, et al. Among authors: igura t. Hepatol Res. 2018 Feb;48(3):E107-E116. doi: 10.1111/hepr.12934. Epub 2017 Aug 7. Hepatol Res. 2018. PMID: 28666312
Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation.
Imai Y, Katayama K, Hori M, Yakushijin T, Fujimoto K, Itoh T, Igura T, Sakakibara M, Takamura M, Tsurusaki M, Takahashi H, Nakanishi K, Usuki N, Tsuji K, Ohashi H, Kim T, Takehara T, Murakami T. Imai Y, et al. Among authors: igura t. Liver Cancer. 2017 Nov;6(4):349-359. doi: 10.1159/000481416. Epub 2017 Oct 19. Liver Cancer. 2017. PMID: 29234638 Free PMC article.
Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
Ohama H, Imai Y, Nakashima O, Kogita S, Takamura M, Hori M, Seki Y, Sawai Y, Igura T, Fukuda K, Makino Y, Morimoto O, Ohsawa M, Sakamoto M, Murakami T. Ohama H, et al. Among authors: igura t. J Gastroenterol. 2014 Jun;49(6):1081-93. doi: 10.1007/s00535-013-0859-1. Epub 2013 Aug 1. J Gastroenterol. 2014. PMID: 23903870
Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.
Makino Y, Imai Y, Igura T, Kogita S, Sawai Y, Fukuda K, Iwamoto T, Okabe J, Takamura M, Fujita N, Hori M, Takehara T, Kudo M, Murakami T. Makino Y, et al. Among authors: igura t. Liver Cancer. 2016 Oct;5(4):269-279. doi: 10.1159/000449338. Epub 2016 Sep 14. Liver Cancer. 2016. PMID: 27781199 Free PMC article.
Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T, Imai Y, Igura T, Kogita S, Sawai Y, Fukuda K, Yamaguchi Y, Matsumoto Y, Nakahara M, Morimoto O, Ohashi H, Fujita N, Kudo M, Takehara T. Iwamoto T, et al. Among authors: igura t. Dig Dis. 2017;35(6):574-582. doi: 10.1159/000480185. Epub 2017 Oct 17. Dig Dis. 2017. PMID: 29040990
Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T, Imai Y, Kogita S, Igura T, Sawai Y, Fukuda K, Yamaguchi Y, Matsumoto Y, Nakahara M, Morimoto O, Seki Y, Ohashi H, Fujita N, Kudo M, Takehara T. Iwamoto T, et al. Among authors: igura t. Dig Dis. 2016;34(6):679-686. doi: 10.1159/000448855. Epub 2016 Oct 17. Dig Dis. 2016. PMID: 27750237
Threshold doses and prediction of visually apparent liver dysfunction after stereotactic body radiation therapy in cirrhotic and normal livers using magnetic resonance imaging.
Doi H, Shiomi H, Masai N, Tatsumi D, Igura T, Imai Y, Oh RJ. Doi H, et al. Among authors: igura t. J Radiat Res. 2016 Jun;57(3):294-300. doi: 10.1093/jrr/rrw008. Epub 2016 Mar 16. J Radiat Res. 2016. PMID: 26983986 Free PMC article.
Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.
Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K. Ito T, et al. Among authors: igura t. Nutr Cancer. 2014;66(3):377-82. doi: 10.1080/01635581.2014.884232. Epub 2014 Mar 10. Nutr Cancer. 2014. PMID: 24611562 Clinical Trial.
49 results
Jump to page
Feedback